Category «Cancer treatment Canada»

Merck canada announces conditional approval of keytruda (pembrolizumab) for melanoma treatment

"Many of us at Merck Canada are thrilled with KEYTRUDA being offered in Canada to treat advanced melanoma, because it provides new therapy to patients facing this difficult-to-treat cancer," stated Chirfi Guindo, Md, Merck Canada Corporation. "This latest product embodies Merck’s unwavering dedication to be the main thing on scientific discovery and innovation to assist …

Be aware of details – pancreatic cancer canada

Pancreatic cancer know no bounds … it may strike anybody, anytime. It’s believed that 5,500 Canadians (53,070 Americans and most 338,000 worldwide) is going to be diagosed with pancreatic cancer in 2016 roughly 4,800 Canadians (41,780 in america) will die. It’s the fourth leading reason for cancer-related dying in Canada and it has lately surpassed …

Immunotherapy for cancer

Navigation article: • Extracorporeal Photopheresis using the Autologous Dendritic Cell Cancer Vaccine • Non-Toxic Autologous Dendritic Cell Cancer Vaccine • Non-Toxic Cancer Of The Prostate Vaccine • Coley’s Mixed Microbial Vaccine • Issels’ Autologous Vaccine Tumour immunology and immunotherapy Video COMMENTS: • Extracorporeal Photopheresis using the Autologous Dendritic Cell Cancer Vaccine Extracorporeal Photopheresis is really a …

Home

INDICATIONS Varithena® (polidocanol injectable foam) is really a prescription drugs accustomed to treat spider veins brought on by issues with the truly amazing saphenous vein (GSV) and other associated veins within the leg’s GSV system. Varithena® improves signs and symptoms associated with or brought on by spider veins, and the look of spider veins. IMPORTANT …

Health canada approves new first-line strategy to women coping with metastatic cancer of the breast

CNW, May 10, 2016 – KIRKLAND, QC Today, Pfizer Canada announced that Health Canada provides conditional approval of IBRANCE™ (palbociclib) which is available these days in Canada. IBRANCE is really a kinase inhibitor indicated in conjunction with letrozole to treat postmenopausal women with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced cancer …